Alpha 2.0
Login Register
» Authors » John H L Matthews

John H L Matthews

Explore the profile of John H L Matthews including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 378
Followers 0
Related Specialties
Oncology
Radiology
General Medicine
Top 10 Co-Authors
Chakiath C Jose
Nigel Spry
Christopher D Scrase
David Joseph
Annette Haworth
John D Graham
Isabel Syndikus
Matthew R Sydes
Nigel A Spry
Gillian M Duchesne
Published In
Radiother Oncol
Lancet Oncol
Oncol Res
Int J Radiat Oncol Biol Phys
N Z Med J
Affiliations
Soon will be listed here.
Recent Articles
1.
Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
Kneebone A, Fraser-Browne C, Duchesne G, Fisher R, Frydenberg M, Herschtal A, et al.
Lancet Oncol . 2020 Oct; 21(10):1331-1340. PMID: 33002437
Background: Adjuvant radiotherapy has been shown to halve the risk of biochemical progression for patients with high-risk disease after radical prostatectomy. Early salvage radiotherapy could result in similar biochemical control...
2.
Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial
Joseph D, Denham J, Steigler A, Lamb D, Spry N, Stanley J, et al.
Int J Radiat Oncol Biol Phys . 2020 Feb; 106(4):693-702. PMID: 32092343
Purpose: To clarify the relative effects of duration of androgen suppression (AS) and radiation dose escalation (RDE) on distant progression (DP) in men with locally advanced prostate cancer. Methods And...
3.
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial
Dearnaley D, Jovic G, Syndikus I, Khoo V, Cowan R, Graham J, et al.
Lancet Oncol . 2014 Mar; 15(4):464-73. PMID: 24581940
Background: The aim of this trial was to compare dose-escalated conformal radiotherapy with control-dose conformal radiotherapy in patients with localised prostate cancer. Preliminary findings reported after 5 years of follow-up...
4.
Barrie David Evans
Matthews J
N Z Med J . 2013 Nov; 126(1378):3 p following 90. PMID: 24180029
No abstract available.
5.
T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02
Matthews J, Burmeister B, Borg M, Capp A, Joseph D, Thompson K, et al.
Radiother Oncol . 2010 Nov; 98(1):93-8. PMID: 21109321
Background And Purpose: Elective inguinal irradiation increases morbidity. We describe outcomes of moderate intensity chemoradiation treating anal canal and adjacent pelvic nodes only. Material And Methods: Forty patients with T1-2,...
6.
The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397)
Dearnaley D, Sydes M, Langley R, Graham J, Huddart R, Syndikus I, et al.
Radiother Oncol . 2007 Mar; 83(1):31-41. PMID: 17391791
Background: Five-year disease-free survival rates for localised prostate cancer following standard doses of conventional radical external beam radiotherapy are around 80%. Conformal radiotherapy (CFRT) raises the possibility that radiotherapy doses...
7.
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
Gogna N, Matthews J, Turner S, Mameghan H, Mameghan H, Duchesne G, et al.
Radiother Oncol . 2006 Oct; 81(1):9-17. PMID: 17011058
Background And Purpose: To determine the feasibility, toxicity, and clinical effectiveness of concurrent weekly cisplatin chemotherapy in conjunction with definitive radiation in the treatment of localised muscle invasive bladder cancer....
8.
Estimation of radiation-induced interphase cell death in cultures of human tumor material and in cell lines
Marshall E, Baguley B, Matthews J, Jose C, Furneaux C, Shaw J, et al.
Oncol Res . 2004 Jun; 14(6):297-304. PMID: 15206492
A short-term assay method able to estimate the radiation response of human cancer tissue samples would be of great advantage to the individualization of radiotherapy in cancer patients. However, the...